-
Full Article (HTML) (124) -
Full Article (PDF) (47) -
Send to Friends (0)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Checklist of Responsibilities for the Scientific Editor of This Article
Publishing Process of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5522)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Nov 7, 2016 (publication date) through Jul 2, 2022
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Dothel G, Raschi E, Rimondini R, De Ponti F. Mesenchymal stromal cell-based therapy: Regulatory and translational aspects in gastroenterology. World J Gastroenterol 2016; 22(41): 9057-9068 [PMID: 27895395 DOI: 10.3748/wjg.v22.i41.9057] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i41/9057.htm |
| Number | Citing Articles |
| 1 |
Renáta Bor, Anna Fábián, Klaudia Farkas, Tamás Molnár, Zoltán Szepes. Human mesenchymal stem cell therapy in the management of luminal and perianal fistulizing Crohn’s disease – review of pathomechanism and existing clinical data. Expert Opinion on Biological Therapy 2018; 18(7): 737 doi: 10.1080/14712598.2018.1492543
|
| 2 |
Mariano Garcia-Arranz, Damián Garcia-Olmo, María Dolores Herreros, José Gracia-Solana, Héctor Guadalajara, Fernando Portilla, Jorge Baixauli, Jacinto Garcia-Garcia, José Manuel Ramirez, Fermín Sanchez-Guijo, Felipe Prosper. Autologous adipose-derived stem cells for the treatment of complex cryptoglandular perianal fistula: A randomized clinical trial with long-term follow-up. Stem Cells Translational Medicine 2020; 9(3): 295 doi: 10.1002/sctm.19-0271
|
| 3 |
Richard Taubert, Katharina Luise Hupa-Breier, Elmar Jaeckel, Michael P. Manns. Novel therapeutic targets in autoimmune hepatitis. Journal of Autoimmunity 2018; 95: 34 doi: 10.1016/j.jaut.2018.10.022
|
| 4 |
Karen Macpherson, Olalekan Lee Aiyegbusi, Lauren Elston, Susan Myles, Jennifer Washington, Nisha Sungum, Mark Briggs, Philip Newsome, Melanie Calvert. A scoping review of patient and public perspectives on cell and gene therapies. Regenerative Medicine 2021; 16(11): 1005 doi: 10.2217/rme-2020-0181
|
| 5 |
Judith Gronbach, Tayyab Shahzad, Sarah Radajewski, Cho-Ming Chao, Saverio Bellusci, Rory E. Morty, Tobias Reicherzer, Harald Ehrhardt. The Potentials and Caveats of Mesenchymal Stromal Cell-Based Therapies in the Preterm Infant. Stem Cells International 2018; 2018: 1 doi: 10.1155/2018/9652897
|
| 6 |
Erica P Turse, Francis E Dailey, Maliha Naseer, Edward K Partyka, Veysel Tahan. One more chance of fistula healing in inflammatory bowel disease: Stem cell therapy. World Journal of Clinical Cases 2018; 6(12): 493-500 doi: 10.12998/wjcc.v6.i12.493
|
| 7 |
Jian Niu, Wang Yue, Zhu Le-Le, Liu Bin, Xin Hu. Mesenchymal stem cells inhibit T cell activation by releasing TGF-β1 from TGF-β1/GARP complex. Oncotarget 2017; 8(59): 99784 doi: 10.18632/oncotarget.21549
|
| 8 |
Mercedes Lopez-Santalla, Raquel Fernandez-Perez, Marina I. Garin. Mesenchymal Stem/Stromal Cells for Rheumatoid Arthritis Treatment: An Update on Clinical Applications. Cells 2020; 9(8): 1852 doi: 10.3390/cells9081852
|